135 related articles for article (PubMed ID: 35679629)
1. Upregulation of viral RNA polymerase activity promotes adaptation of SSPE virus to neuronal cells.
Sakamoto K; Satoh Y; Takahashi KI; Wakimoto H; Kitagawa Y; Gotoh B; Ayata M; Itoh M
Virology; 2022 Aug; 573():1-11. PubMed ID: 35679629
[TBL] [Abstract][Full Text] [Related]
2. Suppression of viral RNA polymerase activity is necessary for persistent infection during the transformation of measles virus into SSPE virus.
Sakamoto K; Konami M; Kameda S; Satoh Y; Wakimoto H; Kitagawa Y; Gotoh B; Jiang DP; Hotta H; Itoh M
PLoS Pathog; 2023 Jul; 19(7):e1011528. PubMed ID: 37494386
[TBL] [Abstract][Full Text] [Related]
3. M protein of subacute sclerosing panencephalitis virus, synergistically with the F protein, plays a crucial role in viral neuropathogenicity.
Satoh Y; Higuchi K; Nishikawa D; Wakimoto H; Konami M; Sakamoto K; Kitagawa Y; Gotoh B; Jiang DP; Hotta H; Itoh M
J Gen Virol; 2021 Oct; 102(10):. PubMed ID: 34643483
[TBL] [Abstract][Full Text] [Related]
4. Analysis of a Subacute Sclerosing Panencephalitis Genotype B3 Virus from the 2009-2010 South African Measles Epidemic Shows That Hyperfusogenic F Proteins Contribute to Measles Virus Infection in the Brain.
Angius F; Smuts H; Rybkina K; Stelitano D; Eley B; Wilmshurst J; Ferren M; Lalande A; Mathieu C; Moscona A; Horvat B; Hashiguchi T; Porotto M; Hardie D
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487282
[TBL] [Abstract][Full Text] [Related]
5. Weak
Shirogane Y; Hashiguchi T; Yanagi Y
J Virol; 2020 Jan; 94(2):. PubMed ID: 31619560
[TBL] [Abstract][Full Text] [Related]
6. Cell-to-Cell Measles Virus Spread between Human Neurons Is Dependent on Hemagglutinin and Hyperfusogenic Fusion Protein.
Sato Y; Watanabe S; Fukuda Y; Hashiguchi T; Yanagi Y; Ohno S
J Virol; 2018 Mar; 92(6):. PubMed ID: 29298883
[TBL] [Abstract][Full Text] [Related]
7. Interaction of the Hemagglutinin Stalk Region with Cell Adhesion Molecule (CADM) 1 and CADM2 Mediates the Spread between Neurons and Neuropathogenicity of Measles Virus with a Hyperfusogenic Fusion Protein.
Takemoto R; Hirai Y; Watanabe S; Harada H; Suzuki T; Hashiguchi T; Yanagi Y; Shirogane Y
J Virol; 2023 May; 97(5):e0034023. PubMed ID: 37166307
[TBL] [Abstract][Full Text] [Related]
8. Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease.
Patterson JB; Cornu TI; Redwine J; Dales S; Lewicki H; Holz A; Thomas D; Billeter MA; Oldstone MB
Virology; 2001 Dec; 291(2):215-25. PubMed ID: 11878891
[TBL] [Abstract][Full Text] [Related]
9. Generation of recombinant adenovirus expressing siRNA against the L mRNA of measles virus and subacute sclerosing panencephalitis virus.
Otaki M; Jiang DP; Sasayama M; Nagano-Fujii M; Hotta H
Microbiol Immunol; 2007; 51(10):985-91. PubMed ID: 17951988
[TBL] [Abstract][Full Text] [Related]
10. Effect of the alterations in the fusion protein of measles virus isolated from brains of patients with subacute sclerosing panencephalitis on syncytium formation.
Ayata M; Shingai M; Ning X; Matsumoto M; Seya T; Otani S; Seto T; Ohgimoto S; Ogura H
Virus Res; 2007 Dec; 130(1-2):260-8. PubMed ID: 17825451
[TBL] [Abstract][Full Text] [Related]
11. Fitness selection of hyperfusogenic measles virus F proteins associated with neuropathogenic phenotypes.
Ikegame S; Hashiguchi T; Hung CT; Dobrindt K; Brennand KJ; Takeda M; Lee B
Proc Natl Acad Sci U S A; 2021 May; 118(18):. PubMed ID: 33903248
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of structural protein genes of the Yamagata-1 strain of defective subacute sclerosing panencephalitis virus. IV. Nucleotide sequence of the fusion gene.
Komase K; Haga T; Yoshikawa Y; Sato TA; Yamanouchi K
Virus Genes; 1990 Jul; 4(2):173-81. PubMed ID: 1698327
[TBL] [Abstract][Full Text] [Related]
13. CADM1 and CADM2 Trigger Neuropathogenic Measles Virus-Mediated Membrane Fusion by Acting in
Shirogane Y; Takemoto R; Suzuki T; Kameda T; Nakashima K; Hashiguchi T; Yanagi Y
J Virol; 2021 Jun; 95(14):e0052821. PubMed ID: 33910952
[TBL] [Abstract][Full Text] [Related]
14. Measles virus mutants possessing the fusion protein with enhanced fusion activity spread effectively in neuronal cells, but not in other cells, without causing strong cytopathology.
Watanabe S; Ohno S; Shirogane Y; Suzuki SO; Koga R; Yanagi Y
J Virol; 2015 Mar; 89(5):2710-7. PubMed ID: 25520515
[TBL] [Abstract][Full Text] [Related]
15. A Novel Peptide Derived from the Fusion Protein Heptad Repeat Inhibits Replication of Subacute Sclerosing Panencephalitis Virus In Vitro and In Vivo.
Watanabe M; Hashimoto K; Abe Y; Kodama EN; Nabika R; Oishi S; Ohara S; Sato M; Kawasaki Y; Fujii N; Hosoya M
PLoS One; 2016; 11(9):e0162823. PubMed ID: 27612283
[TBL] [Abstract][Full Text] [Related]
16. Measles viral load may reflect SSPE disease progression.
Kühne Simmonds M; Brown DW; Jin L
Virol J; 2006 Jun; 3():49. PubMed ID: 16790043
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of measles virus and subacute sclerosing panencephalitis virus by RNA interference.
Otaki M; Sada K; Kadoya H; Nagano-Fujii M; Hotta H
Antiviral Res; 2006 Jul; 70(3):105-11. PubMed ID: 16530274
[TBL] [Abstract][Full Text] [Related]
18. Amino acid substitutions in the heptad repeat A and C regions of the F protein responsible for neurovirulence of measles virus Osaka-1 strain from a patient with subacute sclerosing panencephalitis.
Ayata M; Tanaka M; Kameoka K; Kuwamura M; Takeuchi K; Takeda M; Kanou K; Ogura H
Virology; 2016 Jan; 487():141-9. PubMed ID: 26524513
[TBL] [Abstract][Full Text] [Related]
19. Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis.
Hall WW; Lamb RA; Choppin PW
Proc Natl Acad Sci U S A; 1979 Apr; 76(4):2047-51. PubMed ID: 287042
[TBL] [Abstract][Full Text] [Related]
20. Full-length sequence analysis of subacute sclerosing panencephalitis (SSPE) virus, a mutant of measles virus, isolated from brain tissues of a patient shortly after onset of SSPE.
Hotta H; Nihei K; Abe Y; Kato S; Jiang DP; Nagano-Fujii M; Sada K
Microbiol Immunol; 2006; 50(7):525-34. PubMed ID: 16858143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
